EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Munro, Kathryn M ^a   Dixon, Kirsty J ^a   Gresle, Melissa M ^a   Jonas, Anna ^b   Kemper, Dennis ^b   Doherty, William ^b   Fabri, Louis J ^c   Owczarek, Catherine M ^c   Pearse, Martin ^c   Boyd, Andrew W ^d   Kilpatrick, Trevor J ^a,b   Butzkueven, Helmut ^a   Turnley, Ann M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c CSL LIMITED   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; EPHRIN RECEPTOR A4; HYBRID PROTEIN; SOLUBLE EPHRIN RECEPTOR A4 IMMUNOGLOBULIN FC FRAGMENT FUSION PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AXONAL INJURY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; IMMUNIZATION; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MICROGLIA; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD; T LYMPHOCYTE; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; ASTROCYTES; AXONS; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE DELETION; IMMUNOGLOBULIN FC FRAGMENTS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECEPTOR, EPHA4; SEVERITY OF ILLNESS INDEX; SPINAL CORD; T-LYMPHOCYTES;

EID: 84873500727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055948     Document Type: Article

References (32)

1. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
2. Barnett MH, Prineas JW, (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55: 458-468.
3. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, et al. (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8: 613-619.
4. Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-31; discussion S43-54.
5. Trapp BD, Nave KA, (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
6. Baxter AG, (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7: 904-912.
7. Gold R, Linington C, Lassmann H, (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
8. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM, (2004) Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 24: 10064-10073.
9. Goldshmit Y, Spanevello MD, Tajouri S, Li L, Rogers F, et al. (2011) EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice. PLoS One 6: e24636.
10. Sobel RA, (2005) Ephrin A receptors and ligands in lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 15: 35-45.
11. Munoz JJ, Alfaro D, Garcia-Ceca J, Alonso CL, Jimenez E, et al. (2006) Thymic alterations in EphA4-deficient mice. J Immunol 177: 804-813.
12. Aasheim HC, Delabie J, Finne EF, (2005) Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood 105: 2869-2876.
13. Holen HL, Nustad K, Aasheim HC, (2010) Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration. J Leukoc Biol 87: 1059-1068.
14. Munro KM, Perreau VM, Turnley AM, (2012) Differential Gene Expression in the EphA4 Knockout Spinal Cord and Analysis of the Inflammatory Response Following Spinal Cord Injury. PLoS One 7: e37635.
15. Herz J, Zipp F, Siffrin V, (2010) Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225: 9-17.
16. Williams A, Piaton G, Lubetzki C, (2007) Astrocytes--friends or foes in multiple sclerosis? Glia 55: 1300-1312.
17. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, et al. (2008) Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol 199: 83-93.
18. Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, et al. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17: 495-499.
19. Herrero-Herranz E, Pardo LA, Gold R, Linker RA, (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. Neurobiol Dis 30(2): 162-173.
20. Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, et al. (2008) Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 86: 3548-3555.
21. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ, (2006) Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53: 696-703.
22. Xu L, Hilliard B, Carmody RJ, Tsabary G, Shin H, et al. (2003) Arginase and autoimmune inflammation in the central nervous system. Immunology 110: 141-148.
23. Parmentier-Batteur S, Finger EN, Krishnan R, Rajapakse HA, Sanders JM, et al. (2011) Attenuation of scratch-induced reactive astrogliosis by novel EphA4 kinase inhibitors. J Neurochem 118: 1016-1031.
24. Coonan JR, Greferath U, Messenger J, Hartley L, Murphy M, et al. (2001) Development and reorganization of corticospinal projections in EphA4 deficient mice. J Comp Neurol 436: 248-262.
25. Dottori M, Hartley L, Galea M, Paxinos G, Polizzotto M, et al. (1998) EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. Proc Natl Acad Sci U S A 95: 13248-13253.
26. Brown DA, Sawchenko PE, (2007) Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol 502: 236-260.
27. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, et al. (2005) Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146-152.
28. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD, (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025-1033.
29. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, et al. (2006) Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116: 905-915.
30. Napoli I, Neumann H, (2010) Protective effects of microglia in multiple sclerosis. Exp Neurol 225: 24-28.
31. Puschmann TB, Turnley AM, (2010) Eph receptor tyrosine kinases regulate astrocyte cytoskeletal rearrangement and focal adhesion formation. J Neurochem 113: 881-894.
32. Benson MD, Romero MI, Lush ME, Lu QR, Henkemeyer M, et al. (2005) Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci U S A 102: 10694-10699.